Britain’s New AI Biosecurity Lab Pairs £100 Million in Public Money With Up to £200 Million in OpenAI and Anthropic Credits

Britain set up its AI Security Institute in 2023 to probe the risks in frontier models. The country’s newest AI body has a different brief, putting those models to work against biological threats, and as much as two-thirds of its backing comes from the companies that make them.

The AI Biosecurity Lab gets £100 million in government money. OpenAI and Anthropic have committed up to £200 million more, in the form of access to their own systems. OpenAI is putting in £100 million in compute and model credits, and Anthropic’s pledge of up to £100 million covers model credits, trusted model access and technical support, the Cabinet Office said. Google DeepMind and Basecamp Research are signed on as research partners.

The lab will be an independent nonprofit, and the government wants it to “move with the speed and focus of a frontier AI–bio company.” Its first projects aim at spotting emerging biological threats earlier and speeding up work on vaccines and treatments.

Where OpenAI’s credits come from

OpenAI’s credits run through Rosalind Biodefense, a program it launched in May to sponsor use of GPT-Rosalind, its life sciences reasoning model, on vetted defensive projects. When the program started, OpenAI also gave access to the Coalition for Epidemic Preparedness Innovations (CEPI). CEPI’s deputy CEO, Aurelia Nguyen, is quoted backing the British lab in the wider announcement. “Rapid advances in AI are creating new risks related to the design and modification of pathogens, increasing the potential for both accidental and deliberate harm,” she said.

The lab is part of an AI package Chancellor John Healey is putting into Wednesday’s Budget, and other line items lean toward security too. The AI Security Institute, which this week published its own analysis of a Mythos 5 test run that went after a real GitHub project, gets an extra £120 million. A National Cyber Shield built on agentic AI gets £60 million.

The lab’s remit also reaches into drug approval. It will work with the Medicines and Healthcare products Regulatory Agency to prepare for health emergencies and to inform how AI-designed medicines are regulated.